5 European Projects Found
Searched on 125080 European Projects
FINISHED
Synthetic Cellular Signaling Circuits (SynSignal)
Start date: Nov 1, 2013, End date: Oct 31, 2017,
Cellular signaling systems are crucially important for a broad range of critical health and disease areas and high value industrial applications. Signaling systems are the target for more than half of the medicines marketed by the pharmaceutical industry, and form the main R&D area for the nutrition, flavour and fragrance industries. SynSignal is a multidisciplinary high-tech consortium working in ...
Read Project
10
Partners Participants
FINISHED
Non-coding RNAs in neurogenic and neuropathic pain mechanisms and their application for risk assessment, patient stratification and personalised pain medicine (NCRNAPAIN)
Start date: Oct 1, 2013, End date: Sep 30, 2017,
Neuro-immune alterations in the peripheral and central nervous system play a role in the pathophysiology of chronic pain, and non-coding RNAs (ncRNAs) regulate both immune and neuronal processes. Therefore, ncRNAPain proposes that ncRNAs are critically important master switches for chronic pain.ncRNAPain represents a multidisciplinary consortium of clinical partners, molecular and systems-level n ...
Read Project
12
Partners Participants
FINISHED
Arrowhead (ARROWHEAD)
Start date: Mar 1, 2013, End date: Feb 28, 2017,
"Our society is facing both energy and competitiveness challenges. These challenges are tightly linked and require new dynamic interactions between energy producers and energy consumers, between machines, between systems, between people and systems, etc. Cooperative automation is the key for these dynamic interactions and is enabled by the technology developed around the Internet of Things and Ser ...
Read Project
87
Partners Participants
FINISHED
European collaborative project on Targeted therapy in renal cell cancer: genetic and tumor-related biomarkers for response and toxicity (EuroTARGET)
Start date: Mar 1, 2011, End date: Aug 31, 2016,
Each year more than 63,000 new cases of kidney cancer are diagnosed in the European Union. Approx. 50% of all patients have metastasized renal cell cancer (mRCC) at presentation or develop metastases during follow-up. 5-year relative survival of mRCC has been extremely poor: between 5 and 10%. In the past few years, so-called targeted therapies that suppress angiogenesis have changed the clinical ...
Read Project
15
Partners Participants
FINISHED
Large grained, low stress multi-crystalline silicon thin film solar cells on glass by a novel combined diode laser and solid phase crystallization process (HIGH-EF)
Start date: Jan 1, 2008, End date: Dec 31, 2010,
HIGH-EF will provide the silicon thin film photovoltaic (PV) industry with a unique process allowing for high solar cell efficiencies (potential for >10%) by large, low defective grains and low stress levels in the material at competitive production costs. This process is based on a combination of melt-mediated crystallization of an amorphous silicon (a-Si) seed layer (2 µm) of the seed layer by a ...
Read Project
